NANOVIRICIDES, INC. Loan Processing Fee
NANOVIRICIDES, INC. (NNVC) reported Loan Processing Fee of $39.30 thousand for the 12-month period ending 2020-06-30, per its 10-K filed 2021-10-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LoanProcessingFee · last filed 2021-10-12
- NANOVIRICIDES, INC. loan processing fee for fiscal 2020 was $39.30K.
| Period end | Loan Processing Fee 12 month |
|---|---|
| 2020-06-30 | $39.30K 10-K · filed 2021-10-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |